Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience

Background: Considering the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the clinical implications of gastrointestinal (GI) and hepatic manifestations of coronavirus disease 2019 (COVID-19) in the U.S. population require analysis. Methods: We retrospectively reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadalavada, Pravallika, Padbidri, Vinay, Garg, Rajat, Alomari, Mohammad, Babar, Arslan, Kewan, Tariq, Ahuja, Keerat R, Contreras, Jose, Al-Jaghbeer, Mohammed J, Sanaka, Madhusudhan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748564/
https://www.ncbi.nlm.nih.gov/pubmed/33365223
http://dx.doi.org/10.7759/cureus.11555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748564/
https://www.ncbi.nlm.nih.gov/pubmed/33365223
http://dx.doi.org/10.7759/cureus.11555

Ejemplares similares